Women without pregnancy complications or maternal risk factors for complications have low rates of significant pelvic floor dysfunction after giving birth, whether they deliver vaginally or via cesarean section, recent research shows.
Prostate cancer genomic tests show prognostic value for progression, therapy benefit
April 22nd 2024"This preplanned ENACT trial biomarker analysis demonstrates the value of the Decipher score, AR-A score, and PAM50 genomic classifiers in identifying patients undergoing AS who are most likely to benefit from enzalutamide treatment," wrote the authors.